# First Mid Bancshares, Inc.: overview

FMBH · Nasdaq · CIK 700565 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fmbh.md) · [Financials](/companies/fmbh/financials.md) · [Filings](/companies/fmbh/filings.md) · [Insiders](/companies/fmbh/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.81](/filings/0001193125-25-272249.md) | not reported | [0.93](/filings/0001193125-26-213797.md) | [0.98](/filings/0001193125-26-339679.md) | [0.94](/filings/0001193125-25-272249.md) | not reported | [1.06](/filings/0001193125-26-213797.md) | [1.04](/filings/0001193125-26-339679.md) |
| Free cash flow | $m | [32.0 d](/filings/0001193125-25-272249.md) | [37.0 d](/filings/0001193125-26-080847.md) | [46.0](/filings/0001193125-26-213797.md) | [6.0 d](/filings/0001193125-26-339679.md) | [31.9 d](/filings/0001193125-25-272249.md) | [40.2 d](/filings/0001193125-26-080847.md) | [23.1](/filings/0001193125-26-213797.md) | [24.2 d](/filings/0001193125-26-339679.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [2.87](/filings/0000950170-24-026921.md) | [3.60](/filings/0000950170-25-029793.md) | [3.15](/filings/0001193125-26-080847.md) | [3.30](/filings/0001193125-26-080847.md) | [3.83](/filings/0001193125-26-080847.md) |
| Free cash flow | $m | [65.9](/filings/0000950170-24-026921.md) | [60.8](/filings/0000950170-25-029793.md) | [68.8](/filings/0001193125-26-080847.md) | [119](/filings/0001193125-26-080847.md) | [124](/filings/0001193125-26-080847.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fmbh/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $114.3m | 2,375,794 |  | Added +307,643 |
| [Ballentine Partners, LLC](/funds/1374889.md) | 2026-06-30 | $80.3m | 1,670,229 |  | Reduced −2,257 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $56.2m | 1,167,770 |  | Added +66,675 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $51.6m | 1,072,533 |  | Added +139,770 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $36.1m | 751,124 |  | Added +94,876 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $31.7m | 659,157 |  | Added +97,608 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $28.1m | 584,436 |  | Added +59,320 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $24.2m | 503,186 |  | Added +60,733 |
| [Boston Partners](/funds/1386060.md) | 2026-06-30 | $22.1m | 459,139 |  | Reduced −3,914 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $16.6m | 344,995 |  | Added +52,686 |

## Recent filings

[All 1,675 filings](/companies/fmbh/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 07:00 ET | [8-K](/filings/0001171843-26-006956.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-006956 |
| 2026-10-29 | 07:00 ET | [8-K](/filings/0001171843-26-006953.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-006953 |
| 2026-10-21 | 15:42 ET | [8-K](/filings/0001171843-26-006740.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001171843-26-006740 |
| 2026-10-16 | 15:32 ET | [SCHEDULE 13D/A](/filings/0001014108-26-000064.md) | Ownership report, active investor, amended | 0001014108-26-000064 |
| 2026-08-07 | 12:01 ET | [10-Q](/filings/0001193125-26-339679.md) | Quarterly report, period 2026-06-30 | 0001193125-26-339679 |
| 2026-07-23 | 08:00 ET | [8-K](/filings/0001171843-26-004848.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-004848 |
| 2026-07-15 | 09:00 ET | [8-K](/filings/0001171843-26-004658.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001171843-26-004658 |
| 2026-05-08 | 10:52 ET | [10-Q](/filings/0001193125-26-213797.md) | Quarterly report, period 2026-03-31 | 0001193125-26-213797 |
| 2026-05-01 | 15:00 ET | [8-K](/filings/0001171843-26-002932.md) | 5.07 Shareholder vote results | 0001171843-26-002932 |
| 2026-04-29 | 17:20 ET | [8-K](/filings/0001171843-26-002841.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-002841 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-080847.md), filed Feb 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 700565
- Tickers: FMBH
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 10:50 ET. No prices; not investment advice.